In this issue:
Validation of NCCN guidelines for CRC
Sunitinib not recommended in mCRC
Axitinib has no effect in mCRC
Aflibercept reviewed
NBCSP will reduce CRC mortality
Low frequency KRAS mutation is significant
EGFR expression not predicti
Please login below to download this issue (PDF)